A partnership to help support the growing evidence for medical cannabis treatment
EMMAC Life Sciences has entered into a research collaboration with Imperial College London, involving the pre-clinical and clinical evaluation of cannabis-derived medicinal products including a feasibility randomised controlled trial for the treatment of perioperative pain, nausea and vomiting in major hepatopancreatobiliary surgery.
The aims of the project are to:
1. Investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer through in vitro and in vivo work
2. Develop a clinical trial protocol for a feasibility randomised controlled trial and undertake necessary tasks related to regulatory pathways and subsequent practical elements of setting up and running such trial
3. Characterise cannabis-based medicinal products in disease models with particular focus on chronic pain, spasticity and cancer